pubmed-article:21164387 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0305065 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0206515 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0681698 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0205281 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C1414461 | lld:lifeskim |
pubmed-article:21164387 | lifeskim:mentions | umls-concept:C0348080 | lld:lifeskim |
pubmed-article:21164387 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:21164387 | pubmed:dateCreated | 2011-2-14 | lld:pubmed |
pubmed-article:21164387 | pubmed:abstractText | We analyzed characteristics of invasive pneumococcal disease cases occurring in Massachusetts after the introduction and use of conjugate vaccine by underlying risk. Among 578 cases with sufficient information, 16% had high-risk or presumed high-risk conditions (HR/PHR), 3% had asthma, and 80% had no known risk (NKR). The most common HR/PHR conditions were disorders associated with immunosuppression. HR/PHR cases tended to be older and were more likely to be hospitalized than were children with NKR. Children with asthma presented with pneumonia more often than children with NKR. | lld:pubmed |
pubmed-article:21164387 | pubmed:language | eng | lld:pubmed |
pubmed-article:21164387 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21164387 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21164387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21164387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21164387 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21164387 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21164387 | pubmed:issn | 1532-0987 | lld:pubmed |
pubmed-article:21164387 | pubmed:author | pubmed-author:PeltonStephen... | lld:pubmed |
pubmed-article:21164387 | pubmed:author | pubmed-author:HsuKatherine... | lld:pubmed |
pubmed-article:21164387 | pubmed:author | pubmed-author:SheaKimberly... | lld:pubmed |
pubmed-article:21164387 | pubmed:author | pubmed-author:StevensonAbbi... | lld:pubmed |
pubmed-article:21164387 | pubmed:author | pubmed-author:Members of... | lld:pubmed |
pubmed-article:21164387 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21164387 | pubmed:volume | 30 | lld:pubmed |
pubmed-article:21164387 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21164387 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21164387 | pubmed:pagination | 251-3 | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:meshHeading | pubmed-meshheading:21164387... | lld:pubmed |
pubmed-article:21164387 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21164387 | pubmed:articleTitle | Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era. | lld:pubmed |
pubmed-article:21164387 | pubmed:affiliation | Section of Pediatric Infectious Diseases, Boston University School of Public Health, Boston University Medical Center, Boston, MA, USA. | lld:pubmed |
pubmed-article:21164387 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21164387 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |